"Designing Growth Strategies is in our DNA"

U.S. Drug Delivery Systems Market Size, Share & Industry Analysis, By Type (Inhalation, Transdermal, Injectable, and Others), By Device Type (Conventional and Advanced), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Country Forecast, 2024-2032

Last Updated: September 30, 2024 | Format: PDF | Report ID: FBI107910

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The U.S. drug delivery systems market size was worth USD 16.28 billion in 2023 and is projected to grow at a CAGR of 4.6% during the forecast period. 


The rising prevalence of various chronic diseases, such as diabetes, Chronic Obstructive Pulmonary Disease (COPD), asthma, and others, in the country, is one of the predominant factors propelling the demand for drug delivery systems. Further, introducing technologically advanced products to enable safe and efficient drug administration also supports market growth.



  • According to the Centers for Disease Control and Prevention 2023 statistics, an estimated 25.0 million people in the U.S. had asthma in 2021. The rising prevalence of such disorders is likely to raise the adoption of drug delivery systems in the country.


The U.S. drug delivery systems market witnessed substantial growth during the COVID-19 pandemic due to an increase in immunization programs in the country. Such programs raised the demand for these devices. This increased the focus of manufacturers on increasing the manufacturing capacities to cater to this demand.


LATEST TRENDS


Rising Collaborations among Pharmaceutical and Medical Device Manufacturers to Propel Industry Expansion


Market players are continuously integrating new and innovative technologies into existing products to increase the efficiency of drug delivery systems. Moreover, pharmaceutical companies are collaborating with device manufacturers for launching technologically advanced products.


Such initiatives and launches are anticipated to increase patient engagement and aid proper disease management.



  • For instance, in March 2022, Sanofi partnered with Enable Injections, a drug delivery company, to advance the development of subcutaneous drug delivery devices for Sarclisa.


DRIVING FACTORS


Request a Free sample to learn more about this report.


Shifting Preference toward Self-Administering Drugs among Patients to Impel Market Growth 


In the current scenario, patients are refraining from visiting clinics to administer drugs. Rather, they are shifting their preference toward safe and convenient self-administering drug delivery systems. Self-administering drug delivery devices improve patient compliance, especially among the geriatric population, and reduce the frequency of hospital and clinic visits, making the process cost-effective.


The rising launch of self-administering injectable drug delivery systems by players to cater to the growing product demand among patients is fueling the U.S. market growth.



  • For instance, in February 2023, AstraZeneca received the U.S. FDA approval for a single-use, pre-filled pen, Tezspire. The launch was focused on self-administration in patients suffering from severe asthma.


The estimated new cancer cases in males were higher than in females in the U.S. Among males, prostate cancer accounted for 26% of the new cases, whereas in females, breast cancer was the leading cancer and accounted for 30% of all the new cases.


RESTRAINING FACTORS


Increase in Product Recalls May Impede the Market Growth


Despite the integration of advanced technology and the launch of new products to cater to the surging demand in the country, the frequency of product recalls due to manufacturing defects or contaminations is likely to hinder the U.S. drug delivery systems market growth.



  • For instance, in March 2022, Adamis Pharmaceuticals Corporation voluntarily recalled a few lots of Symjepi (epinephrine pre-filled injections) from the consumer level. The batch lots of the recalled product included 21101Y, 21041W, 21081W, and 21102W. The batches were recalled owing to the potential clogging of the epinephrine pre-filled injections dispensing needle.


SEGMENTATION


By Type Analysis


Based on type, the market is segmented into inhalation, transdermal, injectable, and others. The injectable segment held the largest share in 2022 and is projected to dominate the market in the upcoming years. The rise in the number of vaccination campaigns and the launch of advanced wearable injections in the country favors market growth. Another factor supporting the segment growth is an increase in the manufacturing capacity of injections by key players to meet the rising demand.



  • For instance, in March 2023, Genixus expanded its manufacturing capacity for KinetiX, a ready-to-administer syringe, by establishing a new manufacturing facility in Concord, California. Through this, the company aimed to expand its portfolio and meet the rising demand for these syringes.


By Device Type Analysis


Based on device type, the market is categorized into conventional and advanced. The conventional segment accounted for the largest share due to easy availability and low cost. Also, shifting manufacturers’ focus to increase the efficiency of these systems by integrating novel technologies is another factor responsible for the increased adoption of these cost-effective devices. Furthermore, increasing approvals and launches of these products for various applications are driving the growth of the market.



  • For instance, in October 2022, Hikma Pharmaceuticals PLC launched the pre-filled succinylcholine chloride syringe. Succinylcholine chloride is used as anesthesia in hospitals and for muscle relaxation during surgery


By Distribution Channel Analysis


Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and others.


The hospital pharmacies segment accounted for the largest share in 2022. These pharmacies are an indispensable part of hospitals. The growing number of hospital visits, increasing number of hospital admissions, rising surgeries, and the growing number of hospitals are a few factors augmenting the demand for drug delivery devices from hospital pharmacies.


The retail pharmacies segment is expected to grow at a significant CAGR during the forecast period. The increase in the availability of drug delivery systems from retail pharmacies and the rise in the number of retail pharmacy outlets are set to promote the segment growth. Also, the rising government initiatives to strengthen the pharmacy sectors in the country contribute to the U.S. market growth.



  • For instance, in June 2023, Walmart announced plans to establish more than 80 specialty pharmacies across 11 states in the U.S.


KEY INDUSTRY PLAYERS


The market is fragmented with the presence of various players. BD, West Pharmaceutical Services Inc., and Baxter are a few key players holding a significant U.S. drug delivery systems market share. The introduction of new products in the market, strategic mergers and acquisitions performed by the companies to expand their geographical reach, and product portfolio are a few factors contributing to their revenue growth.



  • For instance, in August 2022, Baxter received the approval of the U.S. FDA for Novum IQ Syringe Infusion Pump.


Other companies, such as Medtronic, Ypsomed, Kindeva Drug Delivery, and others, also operate in the market. The increasing focus of these players on increasing manufacturing capacities and the launch of new products is anticipated to increase their market share.


LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS: 



  • April 2023- CSL received the FDA approval for an immunoglobulin pre-filled syringe, Hizentra to treat patients living with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Primary Immunodeficiency (PI). The injection is ready to use and provides convenience in drug delivery

  • April 2023- Medtronic received the U.S. FDA approval for Minimed 780G system integrated with Guardian 4 sensor, an insulin pump with meal detection technology.

  • March 2023 – Pfizer received the FDA clearance for Zavzpret, a calcitonin gene-related peptide receptor antagonist nasal spray indicated for the treatment of acute migraine in adults.


REPORT COVERAGE


An Infographic Representation of U.S. Drug Delivery Systems Market

To get information on various segments, share your queries with us



The market research report provides a detailed analysis of the market. It focuses on key aspects such as an overview of the technological advancements, the prevalence of chronic diseases in the U.S, new product launches, key industry developments such as mergers, partnerships, & acquisitions, and the impact of COVID-19 on the market. Additionally, the report will provide key market tends, impact of COVID-19, and others. Besides this, the report also offers insights into the market trends and highlights key industry dynamics. In addition to the aforementioned factors, it encompasses several factors that have contributed to the growth of the market in recent years.


Report Scope & Segmentation
















































  ATTRIBUTE



  DETAILS



Study Period



2019-2032



Base Year



2023



Estimated Year



2024



Forecast Period



2024-2032



Historical Period



2019-2022



Growth Rate



CAGR of 4.6% from 2024 to 2032



Unit



Value (USD Billion)



Segmentation



By Type



  • Inhalation

  • Transdermal

  • Injectable

  • Others



By Device Type



  • Conventional

  • Advanced



By Distribution Channel



  • Hospital Pharmacies

  • Retail Pharmacies

  • Others






Frequently Asked Questions

Fortune Business Insights says that the U.S. market was worth USD 16.28 billion in 2023.

The market is expected to exhibit a CAGR of 4.6% during the forecast period (2024-2032).

By type, the injectable segment held a leading share in the market.

BD, West Pharmaceutical Services Inc., and Baxter, among others are the major players in the market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts
Speak to an Expert
  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X